Andrew J Murphy insider trades
Open-market stock purchases and sales by Andrew J Murphy, Co-Chief Scientific Officer at Regeneron Pharmaceuticals, Inc, from SEC Form 4 filings since Dec 11, 2019.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $167K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $4.5K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $26.5K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $12.1K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $18.2K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $10.6K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $56.3K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $20.6K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $207K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $214K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $147K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $80.7K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $97.7K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $9.2K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $218K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $163K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $173K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $93.7K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $292K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $51.2K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $29.6K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $354K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $296K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $361K |
| Oct 14, 2026 | REGN Regeneron Pharmaceuticals, Inc | Sold | $39.1K |
Companies traded
- REGN Regeneron Pharmaceuticals, Inc: 233 sales, last Oct 14, 2026